Pharmacokinetics of irinotecan and its metabolites

被引：0
|
作者：
Siderov, J [1 ]
机构：
[1] Austin & Repatriat Med Ctr, Heidelberg, Vic, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2002年 / 20卷 / 23期
关键词：
D O I：
10.1200/JCO.2002.99.190
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4609 / 4609
页数：1
相关论文
共 50 条
  • [1] Clinical pharmacokinetics of irinotecan and its metabolites: A population analysis
    Xie, R
    Mathijssen, RHJ
    Sparreboom, A
    Verweij, J
    Karlsson, MO
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) : 3293 - 3301
  • [2] Clinical pharmacokinetics of irinotecan and its metabolites in relation with diarrhea
    Xie, RJ
    Mathijssen, RHJ
    Sparreboom, A
    Verweij, J
    Karlsson, MO
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (03) : 265 - 275
  • [3] PHARMACOKINETICS OF IRINOTECAN AND ITS METABOLITES IN HUMAN BLOOD, BILE, AND URINE
    LOKIEC, F
    CANAL, P
    GAY, C
    CHATELUT, E
    ARMAND, JP
    ROCHE, H
    BUGAT, R
    GONCALVES, E
    MATHIEUBOUE, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 36 (01) : 79 - 82
  • [4] Effect of erlotinib on the pharmacokinetics of irinotecan and its metabolites: A drug-drug interaction study.
    Sanematsu, Emiko
    Toyooka, Issei
    Takashima, Yuki
    Okimoto, Tamio
    Tsubata, Yukari
    Saito, Hideyuki
    Isobe, Takeshi
    Hamada, Akinobu
    CANCER RESEARCH, 2013, 73 (08)
  • [5] Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children’s oncology group
    Patrick A. Thompson
    Manish Gupta
    Gary L. Rosner
    Alexander Yu
    Jeffrey Barrett
    Lisa Bomgaars
    Mark L. Bernstein
    Susan M. Blaney
    John Mondick
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 1027 - 1037
  • [6] Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children's oncology group
    Thompson, Patrick A.
    Gupta, Manish
    Rosner, Gary L.
    Yu, Alexander
    Barrett, Jeffrey
    Bomgaars, Lisa
    Bernstein, Mark L.
    Blaney, Susan M.
    Mondick, John
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (06) : 1027 - 1037
  • [7] Biliary excretion of irinotecan and its metabolites.
    Itoh, T
    Takemoto, I
    Itagaki, S
    Sasaki, K
    Hirano, T
    Iseki, K
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2004, 7 (01): : 13 - 18
  • [8] PHARMACOKINETICS OF OLSALAZINE AND ITS METABOLITES
    VANHOGEZAND, RA
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1988, 23 : 17 - 20
  • [9] Pharmacokinetics of irinotecan and its metabolites SN-38 and ABC in children with recurrent solid tumors after protracted low-dose irinotecan
    Ma, MK
    Zamboni, WC
    Radomski, KM
    Furman, WL
    Santana, VM
    Houghton, PJ
    Hanna, SK
    Smith, AK
    Stewart, CF
    CLINICAL CANCER RESEARCH, 2000, 6 (03) : 813 - 819
  • [10] PHARMACOKINETICS OF ATRACURIUM AND ITS METABOLITES
    WARD, S
    WEATHERLEY, BC
    BRITISH JOURNAL OF ANAESTHESIA, 1986, 58 : S6 - S10
12345